10-Q: Surgery Partners Reports Q1 2025 Results: Revenue Up, Net Loss Widens

Surgery Partners' Q1 2025 revenue increased by 8.2%, but the net loss attributable to the company widened to $37.7 million.

Summary

• Surgery Partners reported an 8.2% increase in revenue for Q1 2025, reaching $776.0 million compared to $717.4 million in Q1 2024.
• The revenue increase is attributed to same-facility revenue growth and the impact of acquisitions and divestitures.
• Days adjusted same-facility revenues increased by 5.2%, driven by a 6.5% increase in same-facility cases, offset by a 1.2% decrease in revenue per case.
• However, the net loss attributable to Surgery Partners, Inc. widened to $37.7 million in Q1 2025, compared to a $12.4 million loss in Q1 2024.
• Adjusted EBITDA increased by 6.6% to $103.9 million, driven by revenue growth and cost management initiatives.
• The company acquired controlling interests in four surgical facilities and one physician practice for $44.0 million.
• As of March 31, 2025, Surgery Partners had $229.3 million in cash and cash equivalents and $388.9 million of borrowing capacity under its Revolver.
• The company owned or operated 164 surgical facilities across 30 states, with a majority interest in 83 facilities and consolidating 118 for financial reporting.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While revenue and Adjusted EBITDA increased, the widening net loss raises concerns. The company's outlook on liquidity is cautiously optimistic.

Positives

• Revenue increased by 8.2% year-over-year, indicating growth in the business.
• Adjusted EBITDA increased by 6.6%, suggesting improved operational efficiency.
• Same-facility case volumes increased by 6.5%, demonstrating increased utilization of existing facilities.
• The company completed strategic acquisitions, expanding its network of facilities.

Negatives

• Net loss attributable to Surgery Partners, Inc. widened to $37.7 million, indicating financial challenges.
• Revenue per case decreased by 1.2%, potentially impacting profitability.
• Interest expense increased to $62.2 million, impacting net income.

Risks

• Broad economic factors, including changes in interest rates, inflation, supply chain risks, and market volatility, could negatively affect the company's payor mix and patient volumes.
• An increase in the amount or deterioration in the collectability of patient accounts receivable will adversely affect cash flows and results of operations.
• If general economic conditions continue to deteriorate or remain uncertain, the company's ability to access capital could be harmed, which could negatively affect liquidity and the ability to repay outstanding debt.

Future Outlook

Based on the current level of operations, the company believes that cash flows from operations, available cash, available capacity on the Revolver, and continued anticipated access to capital markets will be adequate to meet short-term (i.e., 12 months) and long-term (beyond 12 months) liquidity needs.

Industry Context

The report reflects the ongoing trends in the healthcare industry, including the shift towards outpatient surgical procedures and the increasing importance of managed care contracts. The company's focus on multi-specialty surgical facilities aims to mitigate risks associated with specific procedure types.

Comparison to Industry Standards

• It is difficult to compare Surgery Partners' results directly to industry standards without specific benchmarks for the ambulatory surgery center (ASC) and surgical hospital sectors.
• However, companies like AmSurg (now part of Envision Healthcare) and United Surgical Partners International (USPI, owned by Tenet Healthcare) are comparable in terms of operating ASCs and surgical facilities.
• Key metrics to compare would include revenue per case, EBITDA margins, and same-facility growth rates.
• Given the increased net loss, Surgery Partners' performance may be lagging behind some of its peers in terms of profitability, despite revenue growth.

Stakeholder Impact

• Shareholders may be concerned about the widening net loss despite revenue growth.
• Employees may be affected by cost management initiatives.
• Patients should not be directly impacted by the financial results, but the company's ability to invest in facilities and services could be affected in the long term.
• Suppliers and creditors may be impacted by the company's liquidity and ability to meet its obligations.

Key Dates

Keywords

Surgery Partners, surgical facilities, ASC, surgical hospitals, revenue, EBITDA, acquisitions, financial results, healthcare, Q1 2025